1. Home
  2. Stock quotes
  3. Sarepta Therapeutics
  4. Financial Statements
  5. Balance Sheet
  6. Cash and Cash Equivalents
Sarepta Therapeutics logo
Sarepta Therapeutics SRPT
$ 121.03 -0.13%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Sarepta Therapeutics Cash and Cash Equivalents 2011-2024 | SRPT

Annual Cash and Cash Equivalents Sarepta Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
428 M 967 M 2.12 B 1.5 B 835 M 371 M 600 M 122 M 80.3 M 73.6 M 257 M 188 M 39.9 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.12 B 39.9 M 583 M

Quarterly Cash and Cash Equivalents Sarepta Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
198 M 384 M 427 M 428 M 542 M 852 M 872 M 967 M 1.04 B 869 M 1.23 B 2.12 B 1.6 B 1.7 B 1.48 B 1.5 B 1.5 B 1.5 B 1.5 B 835 M 835 M 835 M 835 M 371 M 371 M 371 M 371 M 600 M 600 M 600 M 600 M 122 M 122 M 122 M 122 M 80.3 M 80.3 M 80.3 M 80.3 M 73.6 M 73.6 M 73.6 M 73.6 M 257 M 257 M 257 M 257 M 188 M 188 M 188 M 188 M 39.9 M 39.9 M 39.9 M 39.9 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
2.12 B 39.9 M 563 M